Thomas Ischinger

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

Patrick W. Serruys, Sigmund Silber, Scot Garg et al. · New England Journal of Medicine · 2010 · 664 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

Stephan Windecker, Patrick W. Serruys, Simon Wandel et al. · The Lancet · 2008 · 652 citations

Medicine, Cardiology, Surgery +17

A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease

Christian W. Hamm, Jacobus Reimers, Thomas Ischinger et al. · New England Journal of Medicine · 1994 · 542 citations · Full text

Medicine, Cardiology, Surgery +10

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

Giulio Stefanini, Bindu Kalesan, Patrick W. Serruys et al. · The Lancet · 2011 · 352 citations

Medicine, Cardiology, Clinical Cardiology +15

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

Patrick W. Serruys, Vasim Farooq, Bindu Kalesan et al. · JACC: Cardiovascular Interventions · 2013 · 331 citations

Medicine, Biomedical Engineering, Cardiology +14